Forward Citations = 32

Loading Chart...

5 inventors (with patents filed for the assignee):

Bernardus Nicolaas Machielse (5 out of 47 patents)

Allan Darling (5 out of 45 patents)

Robert Zeiser (1 out of 3 patents)

4. Justus Duyster (1 out of 2 patents)

5. Petya Apostolova (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12491248 - Method for generating immunoregulatory cells in a blood-derived sample (2025-12-09),

2. 10933083 - Hydroxypropyl beta-cyclodextrin compositions and methods (2021-03-02),

3. 10709730 - Hydroxypropyl beta-cyclodextrin compositions and methods (2020-07-14),

4. 10300086 - Hydroxypropyl beta-cyclodextrin compositions and methods (2019-05-28),

5. 10258641 - Hydroxypropyl beta-cyclodextrin compositions and methods (2019-04-16),

6. 9675634 - Hydroxypropyl beta-cyclodextrin compositions and methods (2017-06-13),

Company Overview

Vtesse, Inc. is a biopharmaceutical company dedicated to developing novel treatments for patients with rare and severe diseases. With a focus on lysosomal storage disorders, Vtesse is committed to advancing innovative therapies to improve the quality of life for patients in need. Through collaboration with academic institutions and research partners, Vtesse is driving forward meaningful advancements in the field of rare disease treatment.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#93 in Rockville, MD

#635 in Maryland

#45,007 in US

Rockville, MD, United States of America

Vtesse Inc

Forward Citations = 32

5 inventors:

Bernardus Nicolaas Machielse (5 out of 47 patents)

Allan Darling (5 out of 45 patents)

Robert Zeiser (1 out of 3 patents)

4. Justus Duyster (1 out of 2 patents)

5. Petya Apostolova (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vtesse Inc. Retrieved from https://idiyas.com/company/vtesse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]